Congcong Zeng
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Xin-Zi-Sheng-Wan decoction alleviates hyperuricemia-associated renal injury by inhibiting RIPK1/RIPK3/MLKL-mediated necroptosis.
Journal: Journal of ethnopharmacology
Published: April 19, 2026
Suppression of STING by Acacetin attenuates renal fibrosis via balancing mitophagy and protective nucleoid-phagy.
Journal: Journal of ethnopharmacology
Published: April 03, 2026
Optimized UPLC-MS/MS Method for the Simultaneous Quantification of Pazopanib and GSK-1268997 and Its Application to Drug-Drug Interaction Studies.
Journal: Drug design, development and therapy
Published: January 01, 2026
Apatinib inhibits CYP1A2-mediated melatonin metabolism: in vitro, in vivo and molecular docking studies.
Journal: Chemico-biological interactions
Published: November 09, 2025
Nephropathy 1 Formula alleviates kidney injury by ameliorating mitochondrial dysfunction and pyroptosis in diabetic nephropathy through the TMAO-mROS-NLRP3 axis.
Journal: Chinese journal of natural medicines
Published: June 28, 2025
Xin-Zi-Sheng-Wan decoction alleviates hyperuricemia-induced renal injury by modulating SPP1-CD44-mediated macrophage infiltration and SRC/FAK/β-catenin signaling pathway.
Journal: Journal of ethnopharmacology
Published: May 11, 2025
Bibliometric and visual analysis of membranous nephropathy literature from 2010 to 2023.
Journal: Frontiers in pharmacology
Published: May 02, 2024
Therapeutic effects of traditional Chinese medicine (Maxingshigan-Weijing Decoction) on COVID-19: An open-label randomized controlled trial.
Journal: Integrative medicine research
Published: July 09, 2021
Jiao-tai-wan for insomnia symptoms caused by the disharmony of the heart and kidney: a study protocol for a randomized, double-blind, placebo-controlled trial.
Journal: Trials
Published: March 23, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026